News for Sensorion SA (SENOF)

Published at

Oct 30, 2024 6:00 PM

by globenewswire.com

mixed

mixed

Advancements in Sensorineural Hearing Loss Clinical Trial Pipeline as 20+ Companies Pave the Way for Future Solutions | DelveInsight

Sensorineural hearing loss (SNHL) is the most common type of hearing loss, caused by damage to the inner ear (cochlea) or the auditory nerve pathways....

WILYY WILLF LLY.MX LLY.DE LLY.BA LLY LILY34.SA LCTX.TA LCTX EAR AKUS AGTC 6823.T 0Q1G.L SENOF OTIC GNNDY GNDCN.MX GGNDF ALSEN.PA

Read more →
Published at

Sep 23, 2022 10:54 AM

by etfdailynews.com

neutral

neutral

Sensorion (OTCMKTS:SENOF) Price Target Cut to €3.00

Read Sensorion (OTCMKTS:SENOF) Price Target Cut to €3.00 at ETF Daily News

SENOF

Read more →
Published at

Sep 22, 2022 12:35 PM

by seekingalpha.com

neutral

neutral

SENSORION SA reports 1H results (OTCMKTS:SENOF)

SENSORION SA press release (SENOF): 1H net loss of Є12.26M.Press Release

SENOF ALSEN.PA

Read more →
Published at

Apr 28, 2022 8:04 AM

by seekingalpha.com

neutral

neutral

SENSORION SA reports FY results

SENSORION SA press release (SENOF): FY Net loss was -€15.1M at 31 December 2021 compared with -€9.0M at 31 December 2020.Cash position of €50M at year-end provides extended cash...

SENOF ALSEN.PA

Read more →
Published at

Aug 26, 2021 4:09 PM

by prnewswire.com

mixed

mixed

3SBio announces 2021 interim results, with strong growth in core businesses and significant progress in clinical development

/PRNewswire/ -- Chinese leading biopharmaceutical company 3SBio (01530.HK) today unveiled its 2021 interim results. 3SBio maintained strong performance in core...

TRSBF SENOF JDCMF

Read more →
Published at

Aug 26, 2021 10:41 AM

by marketscreener.com

mixed

mixed

3SBio : announces 2021 interim results, with strong growth in core businesses and significant progress in clinical development

August 25, 2021, Hong Kong --- Chinese leading biopharmaceutical company 3SBio（01530.HK) today unveiled its 2021 interim results. 3SBio maintained strong performance in core businesses,... | August 26, 2021

TRSBF SENOF JDCMF

Read more →
Published at

May 26, 2021 11:03 PM

by marketscreener.com

mixed

mixed

Achilles Therapeutics : THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION (Form 6-K)

THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt as to the action to be taken, please seek your own financial advice from... | May 26, 2021

TEAM.L SENOF ALSEN.PA ACHL 0RNP.L 0HLQ.L SYNC.L RNA RCKT PODD HOOK EPZM ALXN 0QZM.L 0K9J.L ETNB

Read more →

News for Sensorion SA (SENOF)

Advancements in Sensorineural Hearing Loss Clinical Trial Pipeline as 20+ Companies Pave the Way for Future Solutions | DelveInsight

Sensorion (OTCMKTS:SENOF) Price Target Cut to €3.00

SENSORION SA reports 1H results (OTCMKTS:SENOF)

SENSORION SA reports FY results

3SBio announces 2021 interim results, with strong growth in core businesses and significant progress in clinical development

3SBio : announces 2021 interim results, with strong growth in core businesses and significant progress in clinical development

Achilles Therapeutics : THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION (Form 6-K)